{"name":"Comanche Biopharma","slug":"comanche-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNY3lRemx0QkdaM3VoZ1JCV1lybGhqSWxzY1FtLXVLMGlJa3A3U29PaG5fNjBHVTZVNzhWdnB4Ui1XUmJYQ2ZGUjhpWHF5M1ZBeGFlVmg0Y2pHeWhCdUVJQm1LUDByYWgwNkhqSXh1M05lRmlQZHZpSzJYeTQyS1N1VVZpLWd6Zmt5Q2Z3SWZEb1k?oc=5","date":"2026-01-09","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Insilico Medicine, Sanofi, Eli Lilly and more - Medical Marketing and Media","headline":"Rx Rundown: Insilico Medicine, Sanofi, Eli Lilly and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOS25RWlRuVXZBNG9pbnotblB5WG1QajBYSnhlWlpFbG9WbDNDYk5YSW5iWW9NYjViNng1Z0JIMWhvcUFtRW5Vb0o0bzRHZ3lhWnJIU0xvT3lxTnpzMmJZRjNCOGI1cmFMQkZXMi1pOXM1RzVOWTZmRExIM0U4TXNLQy1wNk9lLXl0Vng4WVBMOFNXS05oZFlma0FYLV9nV0VxTGxtUw?oc=5","date":"2025-08-04","type":"pipeline","source":"statnews.com","summary":"Gates Foundation pledges $2.5 billion to women’s health initiatives - statnews.com","headline":"Gates Foundation pledges $2.5 billion to women’s health initiatives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxPN202TUJ4Nm1xZ3AwUEFZbjh0cGl1NWc5WDJFLW03VHhlZnV0R28wOFR4UC0wNlJnSHV6WVY4aG9mdEtDZ1phbHdKWnUyaEhuTzUteERfdkpJdnA1S1VZVGp3TlpwcXhxeEJZeEttTzYwZlNKTHBtZ0dXVGhtSnZZeUs3bkxhTFpVZ2d0c3d5Mm83eGtlRmZJU3FseW5lYVhoeVBESV8zRW9fb1FPTk1jd1ZUb1dyeGlrTFBuMUhCcFBzTnI2azJadG9fWHlxVS1RX0Roc3NNbnIwS19aVEJXbE5zQUJBUHVwdDhhYlluVGZhcXlRVW1wak5xazJ2bFlNMmFzaV9oVENvOWRsTEJFdVRwc2Z3TURveTlIRkJRQXpLV3JWTldMRnBwZG1EdEJSVGdTVlhUVktvS3drSHFrTGFZUmhpcnpOUXl2cEN5OERFZVpE?oc=5","date":"2025-06-17","type":"trial","source":"GlobeNewswire","summary":"Oligonucleotides Clinical Trial Pipeline Analysis - GlobeNewswire","headline":"Oligonucleotides Clinical Trial Pipeline Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxObVlyTUMyb3YzbndfWEpJN3pteU5IQVBxQ3R5Ym1OOVRJVkJCaTVBUmZuQVNDajU2dlRJVjBsamVoM3Z4c282ZVZNdzlxdVdmVHpPZHl6Nk51aEpRTFZIUkExZnZzYk1yREdvZDl4SldsejJ3MHRCNWhoNmdQQXlQWFNsdW9HYnRT?oc=5","date":"2024-01-19","type":"pipeline","source":"pharmaphorum","summary":"BridgeBio raises $1.25bn, and other biotech financings - pharmaphorum","headline":"BridgeBio raises $1.25bn, and other biotech financings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQOGtZbG00N1Y4cGVCcXR6NEpFY0VqU0h4ZGpRQ3FadGpXOFdSeXZ1UzYtNXF2ZlpGd1BMaGRWNFpoM0lxRWtlS0xEb2szcDdEa25FNTVNNDlNRTlzREJJcjlPeEI3dGl2TXY1THBpV3I5SlFWeU9vdGVQYjM0T3lmMXNMcE45QXlDSXc2WjBUeTJUbjhmdnRJS1huVTBrdlBpX2hFbHVoQ2szX0RpNklvazJ6SQ?oc=5","date":"2024-01-19","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Hardy replaces BioMarin’s commercial chief in first big move as CEO - Fierce Biotech","headline":"Chutes & Ladders—Hardy replaces BioMarin’s commercial chief in first big move as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPRHcyaE9vZmF3MnFnc1FsUHlPaVZqckEtVktLdGVTQ1lxVzZ4Y21wOVpidTFNeEI4bEx1SW1sallYMGtzSmw5MjJrekZiMVVvbFJiMUpoWHlER3F6bk0xV2RDTWE0S1Iwc3E3MUF5UXA2eE1TcERsSVFreXFuMkItRjdtQ09kM2RFMVhyMHJtRkkwWllMUGhqanJiMmxKY0lF?oc=5","date":"2024-01-18","type":"pipeline","source":"Pharmaceutical Technology","summary":"Comanche raises $75m to develop preeclampsia therapy - Pharmaceutical Technology","headline":"Comanche raises $75m to develop preeclampsia therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNb1N1cVBSZTFRQzVXZEd3UTFCZDAxOU5LSmdIZUVXUXVSS29mYTM2enFPRkNhQ0d5Q0xheDh1M2dZWlBXbEFaeUZWTHlHOVRxdjF3MWNfdFpwa3FLVU1sbVFnYmcyRTViMmpYYmx3T2ROYUpzaEppNy0yeDNNRFJ0X0xUa093cXRLYWVnbklGQlRqOFBa?oc=5","date":"2024-01-17","type":"pipeline","source":"BioPharma Dive","summary":"Comanche Biopharma raises $75M to fund preeclampsia drug testing - BioPharma Dive","headline":"Comanche Biopharma raises $75M to fund preeclampsia drug testing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxONjI2THYyOU9rbVhMMDRXU1JWNF9zcjRaT0R2TXR3SU5iQTktN1FYTlY1YzQzSkstRVFGZGxsOWg1RThVWENZTkRmemYyMEhBZzZFWUJZZ2h1YVJzN1NKaVpBSmMzWEU0TXlUbVhaZ0JtLTZDZmxiM1JEU1dBcU1PMg?oc=5","date":"2024-01-04","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5KYWltUm5DS0RXdklEaGJOdkhEd0kzcU5DNTNsdVhXMkQ2Q0VSaW55OGY5OWxSSHdoTlVsUnVicHNzWE9UM1lJRXhhY09xU3RhMmFQeTZRM2tuZE5jUkM4V2FDQjlQUWMyN1VNalFjbjVZOG45SHdGVTd6a3A?oc=5","date":"2023-08-28","type":"pipeline","source":"Fierce Biotech","summary":"Introducing Fierce Biotech's 2023 Fierce 15 - Fierce Biotech","headline":"Introducing Fierce Biotech's 2023 Fierce 15","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPSUhubkpmbnFDNnVCMUJ5NUE3QW43NDFfMXo3ZUNhRXRIbjgwdGNUZ3VRV2tRcllIVGdmWUhTOGZPSzJMd2NkWlFFMjJRWFZnTjlxUExRcWM0WWdNTi1ZbUhYaVNUMktuRFlpaEFNcjB4c0d5dmtJN09MYllWSEdkX3NwQV9STUVvLVlvSVdoLVFqeHdzZ0M3NWt2U2otMENWMDdiTFhiN3BRMXZq?oc=5","date":"2022-06-15","type":"pipeline","source":"Inside Precision Medicine","summary":"Top 5 RNA Therapeutics Companies to Watch in 2022 - Inside Precision Medicine","headline":"Top 5 RNA Therapeutics Companies to Watch in 2022","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}